Venus Concept Exchanges Debt for Preferred Stock, Reducing Debt by 24%

TORONTO, ON — October 2, 2025 — Leads & Copy — Venus Concept Inc. (NASDAQ: VERO) announced that on September 30, 2025, it exchanged the full $11.48 million balance of its subordinated convertible notes held by affiliates of Madryn Asset Management, LP for 545,335 shares of its Series Y preferred stock. Following the transaction, the Company’s total debt obligations were approximately $30.1 million, a reduction of 24% compared to $39.7 million outstanding as of December 31, 2024.

Rajiv De Silva, Chief Executive Officer of Venus Concept, stated that Madryn’s partnership has provided financial flexibility as the company works towards sustained long-term growth and profitability. Avinash Amin, MD, Managing Partner at Madryn Asset Management, LP, expressed support for Venus’ efforts to return to growth, noting that the debt-to-equity exchange is intended to advance Venus’ journey towards completing its transformation plan.

Venus Concept is a global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies, reaching over 60 countries and 9 direct markets. The company’s product portfolio includes aesthetic device platforms and hair restoration systems.

Investor Relations Contact: Mike Piccinino, CFA VenusConceptIR@icrhealthcare.com

Source: Venus Concept

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.